Source: PR Newswire — 2026-07-08
Summary
Pearl Health, which builds AI-driven clinical intelligence and risk-analytics tools for Medicare value-based care, closed $110M — $50M in equity led by a16z with Viking Global, AlleyCorp, and Ulysses Capital, plus a $60M Trinity Capital credit facility — to expand its platform and push into Medicare Advantage.
Key Takeaways
- Manages roughly $3.6B in annualized medical spend, up from $2.4B and $1.6B in prior years, across 10,000+ providers in 40+ states covering 250,000+ Medicare beneficiaries.
- The company reached profitability in 2025 while continuing aggressive growth, and is projecting $500M in gross savings while tripling its patient base from 2024 to 2026.
- Funds are earmarked for enterprise health-system and payer partnerships and new Medicare Advantage risk offerings.
- Reflects continued investor appetite for AI tools tied directly to measurable value-based-care outcomes rather than general clinical documentation.